Invention Grant
- Patent Title: Bromodomain inhibitors
- Patent Title (中): 溴代抑制剂
-
Application No.: US14203651Application Date: 2014-03-11
-
Publication No.: US08980879B2Publication Date: 2015-03-17
- Inventor: Dachun Liu , John Pratt , Le Wang , Lisa A. Hasvold , Andrew Bogdan
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Glen J. Gesicki
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D487/04 ; A61K31/407 ; A61K31/437 ; A61K31/5025 ; A61K31/519 ; A61K31/18 ; C07D471/16 ; C07D471/12 ; C07D471/22
Abstract:
The present invention provides for compounds of formula (I) wherein R1, R2, R6, Y1, Y2, A1, A2, A3, and A4 have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).
Public/Granted literature
- US20140256710A1 BROMODOMAIN INHIBITORS Public/Granted day:2014-09-11
Information query
